that will be great, but is it possible?

First 3 Last

Share
Profile

Follow
Suwang

2,197 Posts.

160

30/10/20

08:36

Post #: 48512249
Share

Originally posted by samfiodiving: ↑

AGM IDEAS

Last year this board selfishly issued them self 10% of the company under the guise of performance and being unable to purchase on market because of inside knowledge LOL

Well not funny but it happened

SO

Would it not be fitting this year for this board to award all its shareholders with a repeat loyalty issue as they did in 2013 after the recent success in conversion of those loyalty bringing the company in around $9mil in revenue

The 2013 award was for roughly 33Percent of the company at that time in return for the vote on the consolidation of our holdings

So would it not be feasible for the company to reward its shareholders on behalf of their support for the last option conversion

So i would like to put forward for you fellow shareholders to think on

This years resolution 1 at this years AGM

I would like to see

A loyalty issue to all shareholders Except management whom have already been rewarded with their previous issue

Which would consist of similar to the 2013 issue 33percent of the companies Shares on issue awarded

Something like

500,000,000 SOI

33% = 166,666,666, new oppis issued conversion price 20c

converted @ 20c = 166,666,666 X 0.20 =$33,333,333.00

1 option issued for every 3 shares held with a 2 year expiry and a conversion of 20c

Giving the company if all shares are converted a total of $33.3 mil into their coffers

This is very generous when you consider management awarded themselves 4 yrs with roughly a 12c conversion with the option of a free conversion YES 0 COST

If the zero cost option is taken by board members then there is no contribution to the company $ wise whatsoever

I am not asking for anything for free but i converted nearly 3mil oppis to support this company tell me am i asking to much for a little reward for being so loyal

not only that that loyalty would benefit the company down the track with a further $33.3Mil bucks

If we are going to suffer dilution then let us all partake in the bonuses being awarded for committing long term to this company

I am asking for 1 oppi for 3 fully paid for our loyalty

Diamond got 4 oppis for evey 1 fully paid for his performance lol

Love to hear fellow shareholders thoughts

Expand

that will be great, but is it possible?

ANP Price at posting: 11.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

There are more pages in this discussion • 68 more messages in this thread...

First 3 Last

Add PER (ASX) to my watchlist

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $72.12M

Open	High	Low	Value	Volume
8.3¢	8.4¢	8.0¢	$99.06K	1.226M

Buyers (Bids)

No.	Vol.	Price($)
1	3500	7.8¢

Sellers (Offers)

Price($)	Vol.	No.
8.0¢	40625	1

View Market Depth

No.	Vol.	Price($)
1	3500	0.078
1	10000	0.077
1	180000	0.076
4	186800	0.075
3	180866	0.074

Price($)	Vol.	No.
0.080	40625	1
0.084	120000	1
0.085	363000	2
0.086	480000	3
0.087	400000	1

Last trade - 16.10pm 19/08/2024 (20 minute delay)

PER (ASX) Chart

that will be great, but is it possible?

Fourfold skarn increase points the way to viable garnet project, says Pure

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

that will be great, but is it possible?

Top Stories

Fourfold skarn increase points the way to viable garnet project, says Pure

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

Good habits matters when it comes to finances

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News